Anti-Bevacizumab ELISA Kit (AB941018)

Aperçu

Numéro de catalogue	AB941018
Description	Anti-Bevacizumab ELISA Kit (AB941018) — Quantitative sandwich ELISA for Anti-Bevacizumab. Sample: Plasma, Serum. Range: 156.25 - 10, 000 ng/mL. Highlights ●Sandwich Format — High specificity, reliable quantification. ●Ready-to-Use — Complete kit with pre-coated plates included.
Type d'échantillon	Plasma, Serum
Plage	156.25 - 10, 000 ng/mL
Numéro d'accès	P15692
Applications	ELISA
Méthode de détection	Colorimetric
Type de test	Quantitative
Retraitement	80-120%
Expédition	2-8 ℃
Stabilité et stockage	The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Spécifications	Bevacizumab
Noms alternatifs	12-IgG1, F(ab)-12 IgG1, Fab-12 IgG1, rhuMAb-VEGF, ABP 215, 216974-75-3
Contexte	Vascular endothelial growth factor A, long form (Bevacizumab) is a ~43 kDa protein. Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A. Involved in protecting cells from hypoxia-mediated cell death. 1. Katsman, M. et al. (2022) Cells 11. PMID: 35455969
Note	For Research Use Only.